This inventor holds 1 USPTO granted patent. Top assignee: Acuitas Therapeutics, Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations of Steven M Hansell in Lipid Nanoparticle Delivery
Introduction
Steven M Hansell is an accomplished inventor based in Vancouver, Canada. He has made significant contributions to the field of pharmaceutical delivery systems, particularly through his innovative work on lipid nanoparticles.
Latest Patents
Hansell holds a patent for "Lipids for lipid nanoparticle delivery of active agents." This patent involves compounds that have a specific structure, which can be utilized as a component of lipid nanoparticle formulations for the delivery of therapeutic agents. The patent outlines the use of these compounds, their compositions, and methods for their preparation.
Career Highlights
Steven M Hansell is associated with Acuitas Therapeutics, Inc., where he applies his expertise in lipid nanoparticle technology. His work focuses on enhancing the efficacy of drug delivery systems, which is crucial for improving therapeutic outcomes.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Steven M Hansell's innovative contributions to lipid nanoparticle technology highlight his role as a key figure in advancing pharmaceutical delivery systems. His patent reflects a commitment to improving therapeutic agent delivery, which has the potential to significantly impact the field of medicine.